Skip to content
10-Q

Quarterly Report

Dyne Therapeutics, Inc. DYN

0001193125-25-266882

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 142.82M sh
Capex Q3 2025 · Sep 30, 2025 $1.44M
Capex Q3 2025 · Sep 30, 2024 $1.3M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$291.38M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$208.03M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $573.61M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $435.45M
Stockholders Equity Q3 2025 · Sep 30, 2025 $691.78M
Stockholders Equity Q3 2025 · Jun 30, 2025 $571.45M
Stockholders Equity Q3 2025 · Mar 31, 2025 $668.97M
Stockholders Equity Q3 2025 · Dec 31, 2024 $629.84M
Stockholders Equity Q3 2025 · Sep 30, 2024 $705.54M
Stockholders Equity Q3 2025 · Jun 30, 2024 $775.19M
Stockholders Equity Q3 2025 · Mar 31, 2024 $478.06M
Stockholders Equity Q3 2025 · Dec 31, 2023 $91.29M
Current Liabilities Q3 2025 · Sep 30, 2025 $59.85M
Current Liabilities Q3 2025 · Dec 31, 2024 $42.26M
Total Liabilities Q3 2025 · Sep 30, 2025 $175.28M
Total Liabilities Q3 2025 · Dec 31, 2024 $61.4M
Current Assets Q3 2025 · Sep 30, 2025 $806.26M
Current Assets Q3 2025 · Dec 31, 2024 $659.28M
Total Assets Q3 2025 · Sep 30, 2025 $867.06M
Total Assets Q3 2025 · Dec 31, 2024 $691.23M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.76
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.74
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.96
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.49
Eps Basic Q3 2025 · Sep 30, 2025 −$0.76
Eps Basic Q3 2025 · Sep 30, 2025 −$2.74
Eps Basic Q3 2025 · Sep 30, 2024 −$0.96
Eps Basic Q3 2025 · Sep 30, 2024 −$2.49
Sga Expense Q3 2025 · Sep 30, 2025 $16.67M
Sga Expense Q3 2025 · Sep 30, 2025 $49.15M
Sga Expense Q3 2025 · Sep 30, 2024 $12.86M
Sga Expense Q3 2025 · Sep 30, 2024 $47.18M
Rd Expense Q3 2025 · Sep 30, 2025 $97.22M
Rd Expense Q3 2025 · Sep 30, 2025 $302.9M
Rd Expense Q3 2025 · Sep 30, 2024 $92.8M
Rd Expense Q3 2025 · Sep 30, 2024 $199.6M
Net Income Q3 2025 · Sep 30, 2025 −$108.04M
Net Income Q3 2025 · Sep 30, 2025 −$334.26M
Net Income Q3 2025 · Jun 30, 2025 −$110.86M
Net Income Q3 2025 · Mar 31, 2025 −$115.36M
Net Income Q3 2025 · Sep 30, 2024 −$97.13M
Net Income Q3 2025 · Sep 30, 2024 −$227.88M
Net Income Q3 2025 · Jun 30, 2024 −$65.1M
Net Income Q3 2025 · Mar 31, 2024 −$65.65M
Operating Income Q3 2025 · Sep 30, 2025 −$113.89M
Operating Income Q3 2025 · Sep 30, 2025 −$352.06M
Operating Income restated Q3 2025 · Sep 30, 2024 −$105.57M
Operating Income Q3 2025 · Sep 30, 2024 −$246.78M